e-learning
resources
Madrid 2019
Sunday, 29.09.2019
Treatment of asthma with monoclonal antibodies
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Systematic review and MAIC of OCS reduction with biologic asthma treatments
A. Bourdin (Montpellier, France), D. Husereau (Alberta, Canada), N. Molinari (Montpellier, France), S. Golam (Gothenburg, Sweden), M. Siddiqui (Chandigarh, India), L. Lindner (Barcelona, Spain), X. Xu (Gaithersburg, United States of America)
Source:
International Congress 2019 – Treatment of asthma with monoclonal antibodies
Session:
Treatment of asthma with monoclonal antibodies
Session type:
Poster Discussion
Number:
1658
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Bourdin (Montpellier, France), D. Husereau (Alberta, Canada), N. Molinari (Montpellier, France), S. Golam (Gothenburg, Sweden), M. Siddiqui (Chandigarh, India), L. Lindner (Barcelona, Spain), X. Xu (Gaithersburg, United States of America). Systematic review and MAIC of OCS reduction with biologic asthma treatments. 1658
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Systematic review: Does antibiotic treatment duration affect the outcomes of asthma and COPD exacerbations?
Source: International Congress 2017 – COPD: microbiome composition and the role of antibiotics
Year: 2017
Evaluating inhaled corticosteroid use among pregnant women with asthma: systematic review and meta-analysis
Source: International Congress 2019 – Asthma treatment: cohorts and real-world studies
Year: 2019
Does the use of inhaled corticosteroids in asthma benefit lung function in the long-term? A systematic review and meta-analysis
Source: Eur Respir Rev, 30 (159) 200185; 10.1183/16000617.0185-2020
Year: 2021
The efficacy and safety of inhaled antibiotics for the treatment of bronchiectasis in adults: a systematic review and meta-analysis
Source: International Congress 2019 – Clinical and translational studies of bronchiectasis and non-TB mycobacterial infection
Year: 2019
Pharmacists and medication adherence in asthma: a systematic review and meta-analysis
Source: Eur Respir J, 52 (2) 1800485; 10.1183/13993003.00485-2018
Year: 2018
Inhaled corticosteroids in asthma and longitudinal change in lung function: a systematic review and meta-analysis
Source: International Congress 2019 – Asthma treatment: cohorts and real-world studies
Year: 2019
Prevalence of nonadherence to controller therapy in adults with severe asthma – a systematic review and meta-analysis
Source: International Congress 2019 – Long-term evaluation and control of airway diseases
Year: 2019
Investigating asthma comorbidities: a systematic scoping review
Source: International Congress 2017 – Many faces of asthma and allergies
Year: 2017
The association between adherence and outcomes in severe asthma: a systematic review
Source: International Congress 2019 – Long-term evaluation and control of airway diseases
Year: 2019
Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective
Source: Eur Respir J, 55 (5) 2001009; 10.1183/13993003.01009-2020
Year: 2020
Efficacy of psychosocial intervention in COPD: a systematic review and meta-analysis
Source: Virtual Congress 2020 – Optimising the benefits of pulmonary rehabilitation
Year: 2020
Clinical effectiveness of triple therapy in the management of COPD: A systematic review
Source: Annual Congress 2010 - Risk factors, prevalence and consequences of COPD
Year: 2010
Medication adherence and the risk of severe asthma exacerbations: a systematic review
Source: Eur Respir J 2015; 45: 396-407
Year: 2015
Asthma control test/Questionnaire for assessing asthma control: Systematic review and meta-analysis
Source: Annual Congress 2012 - Asthma: assessment and treatment
Year: 2012
Automated chart review for assessing adherence to asthma guidelines for asthma triggers
Source: International Congress 2018 – Asthma: clinical screening tools
Year: 2018
Consequences of long-term oral corticosteroid therapy and its side-effects in severe asthma in adults: a focused review of the impact data in the literature
Source: Eur Respir J, 52 (4) 1800703; 10.1183/13993003.00703-2018
Year: 2018
The efficacy and safety of adjunctive corticosteroids in the treatment of tuberculous pleurisyA systematic review and meta-analysis
Source: International Congress 2017 – TB: diagnosis, severity and practical management
Year: 2017
Omalizumab reduces asthma exacerbations and oral corticosteroid use in patients with severe allergic asthma: a systematic review of observational studies
Source: International Congress 2019 – Clinical studies of asthma treatments
Year: 2019
Effect of smoking on tuberculosis treatment outcomes: A systematic review and meta-analysis
Source: Virtual Congress 2021 – Epidemiology and burden of tuberculosis and other lung diseases
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept